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1. Zusammenfassung in deutscher Sprache 
Einleitung 
Muskuloskeletale Erkrankungen sind sehr verbreitet und stellen weltweit die häufigste 
Ursache von chronischen Schmerzen und dauerhaften Behinderungen dar. Das neu 
geschaffene Feld der regenerativen Medizin bietet heutzutage vielversprechende 
Lösungsansätze zur Behandlung von Problemen, die durch den Substanz- oder 
Funktionsverlust von Knorpel und Knochen entstehen (Sun et al., 2011), allen vorweg 
die Möglichkeiten des sogenannten „Tissue Engineering“, also die in vitro Züchtung von 
biologischem Organ- oder Gewebeersatz durch die Kombination von Zellen und 
Wachstumsfaktoren in einem geeigneten Trägermaterial zur späteren Implantation in 
einen geschädigten Bereich. Die in vitro Herstellung von Knorpelersatz aus 
körpereigenen Chondrozyten und einer Gelmatrix als Trägermaterial  hat sich als 
„Matrix-assistierte autologe Chondrozyten-Implantation" als erste echte „Tissue 
Engineering“ Anwendung – wenn auch nicht unumstritten –  fest in der klinischen Praxis 
etabliert (Ducheyne et al., 2012).  
Die natürliche Regeneration aller muskuloskeletalen Gewebe geht von einem 
gemeinsamen Pool an Vorläuferzellen aus, den mesenchymalen Stammzellen. Sie 
können mit großer Effizienz isoliert und in der Zelllkultur vermehrt werden, und darüber 
hinaus dazu gebracht werden, sich unter definierten Zellkulturbedingungen in 
verschiedene Gewebe zu differenzieren, so auch in Chondrozyten und Osteoblasten, 
was sie zu interessanten Kandidaten für „Tissue Engineering“-Anwendungen macht 
(Zomorodian und Baghaban Eslaminejad, 2012), zum Beispiel zur Behandlung großer 
Knochendefekte. Es wird jedoch angenommen, dass insbesondere bei großen Defekten 
die eingeschränkte Versorgung mit Sauerstoff und Nährstoffen einen limitierenden 
Faktor für die Verwendung von gezüchteten Geweben darstellt. Stammzellen benötigen 
zum Überleben eine relativ nährstoffreiche und sauerstoffreiche Umgebung (Cancedda 
et al., 2007). Gelenk-Chondrozyten könnten hier einen Vorteil bieten. Knorpel ist ein 
avaskulares Gewebe, weswegen die Chondrozyten an reine Diffusion zur Nährstoff- und 
Sauerstoffversorgung adaptiert sind. Die Hauptfunktionen der Chondrocyten sind es, 
eine Gleitoberfläche im Gelenk zu bilden, und als embryonaler Knorpel eine Schablone 
für das Wachstum von Knochenstrukturen, sowie die späteren Wachstumsfugen der 
Knochen zu bilden. (Archer und Francis-West, 2003). Knorpel kann zudem durch den 
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Vorgang der enchondralen Ossifikation in Knochen umgewandelt werden, weshalb es 
sich lohnen könnte, auch primäre Chondrozyten als Kandidaten für die Herstellung 
größerer Knochenersatz-Implantate zu betrachten.  
Grundsätzlich sind es dieselben Mechanismen, die für die Knochenbildung in der 
Wachstumsfuge und die Regeneration nach Knochenverletzungen verantwortlich sind 
(Kolar et al., 2010). Diese enchondrale Ossifikation wird von zahlreichen Faktoren, 
sowohl systemisch als auch lokal, hochkomplex gesteuert (Kronenberg, 2003). Unter 
diesen Faktoren findet sich auch das Schilddrüsenhormon Triiodthyronin (T3) und das 
Glukokortikoid Dexamethason (Siebler et al., 2001).  
Obwohl die Zellen des Gelenkknorpels hochspezialisiert sind, behalten sie offenbar ihre 
veranlagten Fähigkeiten, in der Skelettentwicklung und Knochenentstehung 
mitzuwirken. Die Expression von Typ X Kollagen, bekannt als Indikatorprotein der 
terminalen Differenzierung von Chondrozyten, wurde z.B. auch in den Chondrozyten 
arthrotischer Gelenke nachgewiesen (Fuerst et al., 2009). Die Rolle, welche die 
Glukokortikoide und das T3 auf die Chondrozyten haben, ist unbefriedigend geklärt, und 
ihre Rolle bei der Induktion oder Inhibition enchondraler Ossifikation bleibt unklar. Ein 
besseres Verständnis dieser Zusammenhänge könnte dabei helfen, einige der Probleme 
bei der in vitro Knochen- und Knorpel-Herstellung zu lösen.  
In dieser Studie untersuchen wir die Effekte der zwei Hormone T3 und Dexamethason 
auf bovine Chondrozyten und auf chondrogen differenzierte Stammzellen. Wir 
formulierten die Hypothese, dass jedes der beiden Hormone gleichsam eine terminale 
Differenzierung in den Zellen induzieren würde, und erwarteten, dass Gelenk-
Chondrozyten und chondrogen differenzierte Stammzellen eine ähnliche Reaktion auf 
die hormonellen Stimuli zeigen würden.    
 
Methoden 
Mesenchymale Stammzellen und primäre Chondrozyten wurden aus bovinem Material 
isoliert, und in einem dreidimensionalen Zellkultursystem aus Alginat (Hauselmann et 
al., 1992) kultiviert. Die mesenchymalen Stammzellen wurden in Alginat chondrogen 
über drei Wochen differenziert, die Chondrozyten ebenfalls in Alginat in serumhaltigem 
Medium für zwei Wochen vorkultiviert. Anschließend wurden die Zellen in definiertem, 
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serum-freiem Medium für fünf Wochen den Hormonen Dexamethason oder 
Triiodthyronin oder einem hormonfreien Kontrollmedium ausgesetzt. Durch 
biochemische und histologische Analysen wurden die Zellen auf ihre Proliferation und 
die Produktion von extrazellulärer Matrix hin untersucht, dabei wurde die Produktion von 
Kollagen und Proteoglykanen, sowie Kalziumablagerungen im Alginat dargestellt. Die 
Expression der mRNA von Kollagen Typ I, II und X wurde mittels quantitativer 
Polymerase-Kettenreaktion (PCR) gemessen. Kollagen X mRNA, sowie die Aktivität der 
alkalischen Phosphatase und die histologische Darstellung von Kalzium dienten als 
Indikatoren der terminalen Differenzierung der Zellen, eine notwendige Vorstufe der 
enchondralen Ossifizierung. Der Effekt der Hormone Triiodthyronin und Dexamethason 
wurde gegeneinander sowie zwischen den beiden Zellarten verglichen. 
 
Ergebnisse 
Die Stammzellen ließen sich im Alginat sehr gut zu einem chondrogenen Phänotyp 
differenzieren, wie sich in der Zunahme der Kollagen Typ II mRNA und der Produktion 
von Proteoglykanen zeigte. Während der Differenzierung kam es zu mäßiger 
Zellproliferation, während sich die Chondrozyten in der zweiwöchigen Vorkultur unter 
Serumeinfluss deutlich vermehrten. 
Die Induktion erfolgte in chemisch definiertem, serum-freien Medium. Die Hormone 
hatten keinen Einfluss auf die Zellproliferation der Chondrozyten oder der Stammzellen. 
Unter Dexamethason-Einfluss produzierten sowohl die Chondrozyten wie auch die 
differenzierten Stammzellen signifikant mehr Proteoglykane als in der Kontroll- oder T3-
Gruppe, nicht aber mehr Kollagen. Die Alzian-Blau Färbung von Gefrierschnitten der 
Alginatkulturen bestätigte diese Ergebnisse. 
Die PCR zeigte, dass T3 in Knorpelzellen die Expression von Kollagen Typ I und II 
mRNA stabilisierte und leicht erhöhte, in den Stammzellen jedoch insbesondere die 
Expression von Typ II mRNA erniedrigte, also einen gegenläufigen Effekt zeigte. Unter 
Dexamethason nahm Kollagen Typ I mRNA als Marker der Dedifferenzierung sowohl in 
Knorpel- wie auch in den Stammzellen signifikant ab, während auf Kollagen Typ II kein 
Einfluss festgestellt wurde.  
Kollagen Typ X mRNA war bereits in frisch isolierten Chondrozyten in überraschend 
hoher Menge nachweisbar, und nahm während der Vorkultur in Alginat rapide ab, und 
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steig nur unter dem Einfluss von T3 wieder an, so dass nach fünf Wochen die mRNA-
Level diejenigen der anderen Gruppen um das 10- bis 20-fache übertrafen. Dies wurde 
begleitet von einem signifikanten Anstieg der Aktivität der alkalischen Phosphatase in 
der T3-behandelten Gruppe. Bei den chondrogen differenzierten Stammzellen dagegen 
hatte T3 diesen Effekt nicht. Kollagen Typ X mRNA erhöhte sich bereits während der 
chondorgenen Differenzierung. In der Hormonbehandlung erhöhte Dexamethason das 
mRNA-Level stark weiter, so dass nach fünf Wochen diese fast 100-fach höhere Werte 
zeigten als in den anderen Gruppen. Auch hier wurde dieser Anstieg von einer erhöhten 
Aktivität der alkalischen Phosphatase in der Dexamethasongruppe reflektiert. 
Histologisch wurde mit der Alizarin-Rot-Färbung nach Kalzium-Depositionen in den 
Kulturen gesucht. In der Tat zeigte sich, in Korrelation zu den Ergebnissen der 
Biochemie und PCR, auch in den histologischen Schnitten eine vermehrte 
Kalziumfärbung in den T3-behandelten Chondrozyten, bzw. den Dexamethason-
behandelten chondrogen differenzierten Stammzellen. 
  
Diskussion 
Die Nutzung des Alginatsystems war in unseren Experimenten wie auch in den 
Ergebnissen anderer  (Garate et al., 2012) zur chondrogenen Differenzierung von 
mesenchymalen Stammzellen erfolgreich, wie der Nachweis von Chondrozyten-
ähnlichen und Proteoglykan-produzierenden Zellen im Alginat bewiesen hat.  
Die Chondrozyten sind nach dem Wechsel zu serumfreiem Medium nicht mehr 
wesentlich proliferiert, und haben im Vergleich zur Vorkultur kaum noch Matrix 
synthetisiert, jedoch ist es auch nicht zu einem Absterben der Zellen gekommen. Diese 
Ergebnisse spiegeln sich auch in der Literatur wieder (Bian et al., 2008). Unter 
Dexamethason-Einfluss produzierten die Zellen schneller mehr Matrix, ein ebenfalls 
vorbekannter Effekt dieses Hormons (Na et al., 2007). Ebenso bestätigte sich in den 
Versuchen die bekannte Erniedrigung von Kollagen Typ II mRNA (Miyazaki et al., 2000), 
ebenso aber auch eine geringere Expression von Kollagen Typ I mRNA. Ob 
Dexamethason also genutzt werden kann, um eine Dedifferenzierung insbesondere 
primärer Chondrozyten zu verhindern, wäre ein interessanter Ansatzpunkt für weitere 
Untersuchungen.  
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Als Marker für die terminale Differenzierung der Zellen haben wir Kollagen Typ X mRNA 
und die Aktivität der alkalischen Phosphatase gemessen, sowie die Kalzium-Deposition 
im Alginat histologisch dargestellt. Der hypertrophierende Effekt von T3 auf die 
Chondrozyten der Wachstumsfuge ist, im Gegensatz zu den Zellen aus der 
Gelenkfläche, besser beschrieben, und auch die zugrundeliegenden Mechanismen sind 
teilweise bekannt (Adams et al., 2007). Parakrine Signalwege über das Parathormon-
verwandte Peptid scheinen die Wirkung der Thyroidhormone unterbinden zu können, 
und diese Signalwege bleiben wohl, als Übertrag aus der Wachstumsfuge, auch im 
„permanenten“ Gelenkknorpel erhalten und aktivierbar (Jiang et al., 2008). In unserer 
Untersuchung konnte T3 auch in Abwesenheit von Dexamethason eine Induktion der 
terminalen Differenzierung von Gelenk-Chondrozyten herbeiführen, was sich in einer 
höheren Expression von Kollagen Typ X mRNA und einer erhöhten Aktivität der 
alkalischen Phosphatase zeigte. Apoptose konnte nicht gezeigt werden, jedoch ist diese 
nicht untrennbar mit der terminalen Differenzierung gekoppelt, und wird über andere 
Signalwege reguliert.  
Wir hatten zudem erwartet, dass chondrogen differenzierte Stammzellen als 
Chondrozyten-ähnliche Zellen in ihrer Reaktion auf die hormonellen Stimuli derjenigen 
von primären Chondrozyten gleichen würden. Dies hat sich nicht betätigt. T3 zeigte, bis 
auf einen leichten aber steigen Abfall in der Expression von Kollagen Typ II mRNA, 
keine Wirkung auf diese Zellen, insbesondere keine Induktion einer terminalen 
Differenzierung. Auffällig war auch, dass in serumfreiem Kontrollmedium ohne 
Dexamethason oder T3 die Stammzellen eine sehr gute phänotypische Stabilität 
aufwiesen, und ebenfalls keine Tendenz zur terminalen Differenzierung zeigten. Dies ist 
wohl auch der Verwendung des Alginats als Kultursystem zuzuschreiben (Studer et al., 
2012).  
Dexamethason ist integraler Bestandteil in allen Differenzierungsmedien für 
mesenchymale Stammzellen. Es ist daher nachvollziehbar, dass eine fortgesetzte 
Supplementierung dieses Hormons auch auf differenzierte Stammzellen weiterhin eine 
Wirkung entfaltet, und damit die Zellen zur terminalen Differenzierung stimuliert. Die 
Zellen sind also Chondrozyten-ähnlich in Bezug auf Matrixsynthese und Morphologie, 
reagieren aber auf Dexamethason mit einem Verlust ihrer phänotypischen Stabilität 
(Derfoul et al., 2006). Zwar bleibt die Expression von Kollagen Typ II mRNA stabil, 
-11- 
 
jedoch erhöht sich die Expression von Kollagen Typ X mRNA signifikant, begleitet von 
erhöhter Aktivität der alkalischen Phosphatase und schließlich Kalzium-Depositionen 
rund um die Zellen. Im Verlauf der Experimente haben wir keine Hinweise darauf 
gefunden, dass Dexamethason die adulten Chondrozyten zur terminalen Differenzierung 
stimuliert.  
Es wird vermutet, dass die chondrogene Differenzierung direkt in eine terminale 
Differenzierung übergehen kann, was sich in unseren Experimenten nur in der 
Anwesenheit von Dexamethason gezeigt hat. Der Phänotyp der Stammzellen scheint 
also, insbesondere unter der Wirkung von Dexamethason, instabil zu sein (Studer et al., 
2012). Während dies in der Gewebezucht von Knorpel große Probleme machen kann, 
kann diese Eigenschaft nutzbar gemacht werden, um dieses Modell der enchondralen 
Ossifizierung für die Herstellung eines zellbasierten Knochenersatzes zu nutzen (Scotti 
et al., 2010).  
Zusammenfassend kommen wir zu dem Ergebnis, dass Chondrozyten zu mehr in der 
Lage sind, als nur eine Knorpelmatrix zu synthetisieren. Ihre terminale Differenzierung 
ist ein wichtiger Prozess in der Knochenbildung und Knochenheilung, und scheint auch 
in der Entstehung degenerativer Gelenkerkrankungen eine Rolle zu spielen. Bisher gibt 
es noch zu wenige Studien an primären Gelenk-Chondrozyten um ihr Potential in der 
Nutzung im Knochen-„Tissue-Engineering“ zu ergründen. Mit unseren Ergebnissen 
konnten wir zeigen, dass T3 ein Induktor der terminalen Differenzierung in Chondrozyten 
sein kann, nicht aber Dexamethason. Gelenk- Chondrozyten sind zu dem nicht 
„permanent“ auf ihre Rolle als solche festgelegt, was in ihrer Nutzung zur 
Knorpelregeneration bedacht werden sollte.  
Die Nutzung von Stammzellen zum „Tissue Engineering“ ist mittlerweile fest etabliert, 
aber ihre phänotypische Stabilität ist und bleibt ein Problem, insbesondere wenn es um 
die Erzeugung von „transientem“ Gewebe wie Knorpel geht. Es bleibt unklar, ob eine 
chondrogen differenzierte Stammzelle stabil genug ist, um zur Knorpelregeneration 
genutzt zu werden, oder früher oder später terminal differenzieren und mineralisieren 
wird. Unsere Ergebnisse unterstreichen die Vorteile des Alginatsystems, sowie die Rolle 
des Dexamethasons in diesem Prozess, und zeigen Möglichkeiten auf, diese Funktion in 
der Konstruktion eines zellbasierten Knochenersatzes zu nutzen.  
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Abstract 
The newly evolved field of regenerative medicine is offering solutions in the treatment of 
bone or cartilage loss and deficiency. Mesenchymal stem cells, as well as articular 
chondrocytes, are potential cells for the generation of bone or cartilage. The natural 
mechanism of bone formation is that of endochondral ossification, regulated, among 
other factors, through the hormones dexamethasone and triiodothyronine. We 
investigated the effects of these hormones on articular chondrocytes and 
chondrogenically differentiated mesenchymal stem cells, hypothesizing that these 
hormones would induce terminal differentiation, with chondrocytes and differentiated 
stem cells being similar in their response. 
Using a 3D-alginate cell culture model, bovine chondrocytes and chondrogenically 
differentiated stem cells were cultured in presence of triiodothyronine or 
dexamethasone, and cell proliferation and extracellular matrix production were 
investigated. Collagen mRNA expression was measured by real-time PCR. Col X mRNA 
and alkaline phosphatase were monitored as markers of terminal differentiation, a 
prerequisite of endochondral ossification.  
The alginate culture system worked well, both for the culture of chondrocytes and for the 
chondrogenic differentiation of mesenchymal stem cells. Dexamethasone led to an 
increase in glycosaminoglycan production. Triiodothyronine increased the total collagen 
production only in chondrocytes, where it also induced signs of terminal differentiation, 
increasing both collagen X mRNA and alkaline phosphatase activity. Dexamethasone 
induced terminal differentiation in the differentiated stem cells.  
The immature articular chondrocytes used in this study seem to be able to undergo 
terminal differentiation, pointing to their possible role in the onset of degenerative 
osteoarthritis, as well as their potential for a cell source in bone tissue engineering. 
When chondrocyte-like cells, after their differentiation, can indeed be moved on towards 
terminal differentiation, they can be used to generate a model of endochondral 
ossification, but this limitation must be kept in mind when using them in cartilage tissue 
engineering application.   
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Introduction 
The two major areas of musculoskeletal medicine are trauma care and degenerative 
disorders. Degenerative joint diseases account for half of all chronic conditions in people 
aged over 65. In young adults, it is foremost traffic accidents that produce a tremendous 
demand for restorative medical attention. It is estimated that traffic injuries worldwide 
result in more than 30 million severe or disabling injuries, with associated costs of 500 
billion US dollars annually [1]. The newly evolved field of regenerative medicine is 
offering new solutions in treating problems arising from loss and deficiency especially of 
cartilage and bone [2]. 
Bone marrow-derived mesenchymal stem cells (MSCs) possess a number of abilities, 
making them interesting candidate cells for tissue engineering applications [3]. They 
have the capacity to differentiate into cells of connective tissue lineages, including bone, 
fat, cartilage and muscle. They can be isolated and expanded with high efficiency, and 
induced to differentiate to multiple lineages under defined culture conditions [4], but no 
routinely available clinical therapy has been generated from this approach. 
In 1994, the transplantation of ex vivo expanded articular chondrocytes into cartilaginous 
defects of the knee joint was one of the first successful applications of tissue 
engineering [5]. Introduced into clinical practice more than two decades ago, the process 
known as autologous chondrocyte implantation (ACI) is now established, but is not free 
of controversies [6]. A dedifferentiation of the implanted chondrocytes towards a more 
fibrous cartilage as well as a terminal differentiation with calcification can occur in the 
implants, both resulting in an inferior joint surface. Scientific attention has therefore 
turned towards the use of MSCs for cartilage regeneration [7], but the phenotypic 
stability of the differentiated MSCs remains a major concern [8].  
Another example for the potential use of tissue engineering in musculoskeletal medicine 
is the management of large bone defects which still pose a considerable challenge in 
musculoskeletal surgery. Other than autologous bone grafting, either in a local fashion 
or through bypass grafting or bone transport, there is no other effective method for 
management of diaphyseal defects [9]. It is already possible to create stable, 
osteoconductive, biocompatible and biodegradable implants, which may release 
osteoinductive molecules and which may be seeded with potentially osteogenic cells 
[10]. Vascularization is essential to bone regeneration and it is generally believed that a 
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limited supply of nutrition due to a lack of blood supply in larger scaffolds is responsible 
for the lack of cell survival. Although diffusion may be sufficient for cells near the 
surface, neovascularization is too slow to supply the cells embedded deep within a graft, 
resulting in graft failure and non-unions. MSCs require a relatively nutrient rich 
environment (including oxygen) for survival [11], therefore the use of articular 
chondrocytes instead might offer an alternative. Cartilage is an avascular tissue, 
therefore chondrocytes have adapted to low oxygen tension and glycolysis for their 
metabolic needs [12].  
Cartilage is routinely transformed into bone in in the process of endochondral 
ossification, during long bone growth and in fracture healing. Here, chondrocytes 
undergo a terminal step of differentiation, increasing in size and finally undergoing cell 
death by apoptosis, leaving behind a suitable matrix for bone ingrowth, vascularization 
and mineralization. This process was initially described in growth plate chondrocytes  
[13] and the fibrous cartilage of the soft fracture callus, but articular chondrocytes do 
seem to keep their abilities associated with skeletal development and bone growth. 
Expression of collagen type X (Col X), known to be a marker of chondrocyte terminal 
differentiation, has been seen in osteoarthritic chondrocytes [14], and was recently also 
shown to be involved in other degenerative diseases like intervertebral disc 
degeneration [15]. Common regulatory pathways and cytokines of regenerative and 
degenerative processes have recently been identified [16]. Among them are also the 
thyroid hormone triiodothyronine (T3) and the glucocorticoid dexamethasone (Dex) [17].  
Though glucocorticoids (GCs) are frequently used in vivo and in vitro on cartilage and 
chondrocytes, their effect on this tissue is not yet fully understood, and their role in 
induction or prevention of endochondral ossification remains ambiguous. GCs signal 
largely through the GC receptor, a member of the nuclear receptor family that 
translocates into the nucleus upon ligand binding and acts as transcription factor [18], 
but the molecular targets of GCs in chondrocytes are largely unknown. Dex has a potent 
anti-inflammatory property and is used in treatment of a wide variety of inflammatory 
conditions such as rheumatoid arthritis. It has also been shown that Dex has a protective 
effect against degradation of cartilage. The anabolic and anti-inflammatory effect leaves 
GCs well established in clinical use [19]. Also Dex seems to be crucial for 
chondrogenesis of MSCs in vitro [20]. Extensive use of glucocorticoids in humans and 
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animals is on the other hand well known to impair longitudinal growth. It has been shown 
that this effect might be caused by induction of apoptosis in chondrocytes of the growth 
plate [21] as well as chondrocytes [22].  
Triiodothyronine, the deiodinated and thereby activated form of the thyroid hormone, 
might well be the most important growth hormone. It affects virtually every cell in the 
organism by binding to its intranuclear receptors T3-Receptor alpha (TRα) and T3-
Receptor beta (TRβ), modifying transcriptional activity on the genome [23]. Its role in the 
regulation of long bone growth and endochondral ossification is crucial [24]. Congenital 
defects in the hormone or its receptor lead to dwarfism and retarded development [25]. 
In vitro, thyroid hormones have been frequently used to induce hypertrophy in fetal and 
growth plate chondrocytes in various culture systems [26,27,28]. Very little research has 
been conducted in the effect of T3 on adult articular cartilage, but it´s possible role in the 
development of OA has been suggested previously [29].  
In this study, we investigated the effects of the two hormones T3 and Dex on primary 
articular chondrocytes and differentiated chondrogenic MSCs, using serum-free 
induction and the alginate bead three-dimensional (3D) cell culture model. The study 
was performed on material of a large animal model (bovine), so the results can be used 
for later establishment of in vivo models for cartilage degradation or bone tissue 
engineering constructs with some biomechanical validity. In addition to cell survival and 
matrix production, the experiments were designed to monitor phenotypic stability and 
furthermore to detect signs of terminal chondrocyte differentiation as a preliminary phase 
of endochondral ossification and mineralization. We hypothesized that both hormones 
will induce terminal differentiation in adult articular chondrocytes and chondrocyte-like 
cells. Furthermore, we expected articular chondrocytes and chondrogenically 
differentiated MSCs to be similar in their response to the hormonal stimuli. 
 
 
-19- 
 
Materials and Methods 
Cell culture 
Chondrocytes were isolated from articular cartilage of bovine fetlock joints from three 
calves (two to six month of age) [30]. Cartilage slices were harvested and washed in 
Tyrode´s balanced salt solution (TBSS, Gibco) containing 10% Penicillin/Streptomycin 
(PenStrep), then pre-digested with 0.1% Pronase (Roche) in Dulbecco´s modified eagle 
medium (DMEM, Gibco) for 120 min. The pre-digested cartilage was washed and 
subsequently digested with 600 U/ml Collagenase II (Roche) in DMEM by stirring 
overnight. The digest was filtered through a 40 µm cell strainer (Falcon), and the cells 
were collected by centrifugation and encapsuled into alginate beads as described below.  
MSCs were isolated from full bone marrow aspirate of two calves (four and six month of 
age) as described in the literature [31]. Bone marrow was aspirated from the tuber 
ischiadicum into sodium heparin immediately after slaughter. The bone marrow sample 
was washed, passed through a 40 µm cell strainer and full bone marrow was then plated 
in 300 cm² culture flasks (TPP, Switzerland) in control medium consisting of DMEM low 
glucose (1g/L) with 1% PenStrep, 25 mM HEPES Buffer (Gibco), 3.7 mg/ml NaHCO3, 
and 10% FCS. After being cultured for four days, non-adherent cells were removed by 
changing the culture medium. In the following, the medium was changed every two to 
three days. Primary cultures were considered passage 0 (P0). Upon subconfluence, the 
cells were detached by using 0.25% trypsin (Gibco) and split in three for the next 
passage. Cells of passage P2 to P3 were encapsuled in the alginate beads and used for 
experiments.  
Alginate is a natural carbohydrate polymer that is derived from brown algae. The 
monomers gelate upon contact with a divalent ion such as calcium, forming an elastic 
hydrogel. Removal of calcium through a chelator unlinks the monomers, thereby 
dissolving the hydrogel and releasing the cells without digestion or disruption [32]. It is 
for these attributes that alginate was early introduced for tissue engineering research, 
especially with chondrocytes [33], and its beneficial effect on the chondrocyte phenotype 
has recently been investigated systematically [34]. For the encapsulation of cells in 
alginate beads, the cells of each individual animal were pelleted and resuspended in 
sterile 0.9% NaCl solution containing 1.2 % sodium alginate to a final concentration of 
4*106 cells / ml, and expressed through a 22-gauge needle in a dropwise fashion into a 
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102 mM calcium chloride (CaCl2) solution. After instantaneous gelation, the beads were 
allowed to polymerize for no more than 10 minutes, washed and cultured in 6-well 
plates, coated with 3% agarose, approximately 30 beads per well in 6 ml of medium [35].  
For differentiation, alginate beads with encapsulated MSCs of passage 2 to 3 were 
grown in a standard chondrogenic medium, consisting of DMEM, supplemented with 1 
µg/ml insulin, 1ng/ml transferrin and 1 ng/ml sodium selenite (ITS+1), 60 µg/ml ascorbic 
acid, 100 nM dexamethasone (all Sigma) and 10 ng/ml transforming growth factor beta-
1 (TGF-ß1, Sigma) for 3 weeks. Alginate beads without TGF-ß1 were cultured as 
controls to evaluate the effect of the three dimensional culture on the cells. MSCs in 
monolayer, receiving standard expansion medium, were used as a negative control. 
Though the standard protocol for chondrogenic differentiation is the pellet culture system 
[36], alginate beads were used so that the cells could be submitted to the same protocol 
as the adult chondrocytes afterwards, but pellet cultures were performed as a positive 
control. For the pellet cultures, 2.5 * 105 MSCs were resuspended in expansion medium 
and were spun down (10 min @ 500g) in a 15-ml conical tube. Pellets received standard 
chondrogenic medium as described above, with TGF-ß1 [37]. Pellets were cultivated at 
37°C in a humidified atmosphere including 5% CO2 with loosened caps for 20 days, 
changing the medium three times per week.  
Alginate beads with cells were kept in agarose-coated 6-well tissue culture plastic dishes 
(TPP, Switzerland) in a cell culture incubator at standard conditions (37°C, 5% CO2, 
humidified atmosphere). The chondrocyte medium was composed of high glucose 
DMEM, supplemented with 1% Pen/Strep, 0.3% Gentamycin, 25mM HEPES Buffer, 60 
µg/ml L-ascorbic acid 2-phosphate and 10% FCS. For hormonal treatment, serum was 
replaced by 1 mg/ml bovine serum albumin, 1 µg/ml insulin, 1ng/ml transferrin and 1 
ng/ml sodium selenite, and the medium was also supplemented with 100nM (=10-7 M) 
triiodo-L-thyronine sodium salt (T3) in 10mM sodium hydroxide (NaOH, Fluka) or 1 µM 
Dex, respectively. Hormone concentrations were adapted from related studies in the 
literature to ensure comparability. Pilot experiments with lower concentrations of the 
hormones showed no significant effect of differences in concentration (data not shown). 
Before start of the hormonal treatment, chondrocyte beads were cultured in DMEM and 
in the presence of 10% FCS to allow for proliferation and matrix production for two 
weeks, and MSCs were differentiated as explained above for 3 weeks. The beads were 
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then kept in hormone supplemented serum free culture for five weeks, with medium 
changes three times a week. Figure 1 illustrates the experimental layout and the 
timepoints.  
To investigate calcification, 10 µM β-glyerophosphate (β-GP) was added to the medium 
of some beads on day 35. The samples were then cultured for a further 7 days and 
harvested. 
 
Biochemistry 
Quantification of (DNA) was carried out using the Hoechst 33258 fluorescent dye as 
described elsewhere [38] with some modifications. Three samples consisting of three 
beads each were taken at each time point and from each group and stored frozen at -
20°C until further analysis. For the assay, the beads were digested in 150 µl/bead 
(approximately 10 volumes) of a dissolution/digestion buffer, consisting of 150 mM NaCl 
(Fluka), 55 mM sodium citrate (Sigma), 5 mM disodium-EDTA (Sigma), 5 mM cystein 
hydrochloride (Fluka) and 125 µg/ml Papain from Papaya latex (Sigma), dissolved in 
Millipore-filtered water. The beads were agitated gently, and incubated at 56°C for 15 
hours. DNA was quantified using bisBenzimide Hoechst-33528 fluorescent dye (Fluka) 
at a concentration of 0.4 µg/ml in Dulbecco’s Phosphate Buffered Saline (DPBS). Calf 
Thymus DNA, diluted in the same digestion buffer as described above was used as 
standard. 40 µl of sample or standard were mixed with 160 µl of the dye in a white-
bottom 96-well-plate (Falcon), incubated for 20 minutes, and fluorescence emission was 
read at 465 nm after excitation at 360 nm in a PerkinElmer HTS 7000 Bio Assay Reader. 
All measurements were done in duplicates, and DNA concentration was calculated from 
fluorescence emission using the linear range of the standard curve. All measurements 
were done in duplicates. 
For hydroxyproline (HYP) detection, 250 µl of the digested sample were mixed with an 
equal volume of 12N HCl (Fluka) and hydrolyzed at 110°C for 12h. Samples were 
neutralized adding 300 µl of 10N NaOH (Fluka), cleared using a charcoal resin mix, pH 
was checked with indicator paper and titrated to neutrality with HCl. A standard curve 
was prepared from a stock solution of trans-4-hydroxy-L-proline (Fluka), and 250 µl of all 
samples and standards was transferred into a fresh 2 ml tube. All samples and 
standards were mixed with 250 µl of saturated NaCl. Oxidation of HYP was reached by 
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addition of 500 µl of a pH 6-buffered Chloramine T solution, containing 120 mmol/l citric 
acid, 440 mmol/l sodium acetate, 425 mmol/l sodium hydroxide, 105 mmol/l acetic acid, 
33 mmol/l Chloramine T trihydrate and 30% v/v 2-Methoxyethanol in water , mixing and 
leaving 20 minutes at room temperature. Color formation occurred after addition of 500 
µl of a color solution, containing 11.25% w/v 4-(Dimethylamino)benzaldehyde, 2 mol/l 
perchloric acid and 50% v/v 1-Propanol in water, and incubating at 65°C for 15 minutes 
[39]. Absorbance was read in a PerkinElmer HTS 7000 Bio Assay Reader at 550 nm, 
and concentration of HYP was calculated from the standard curve. All measurements 
were done in duplicates. 
Total sulfated proteoglycans (GAGs) were quantified as a marker of matrix synthesis in 
the alginate beads, using the dimethylmethylene blue assay as described elsewhere. 
The dye is known to give a positive reaction with alginate, which is constant over a 
broad range of values, and the problem can be circumvented by some modifications of 
the assay [40]. Samples prepared for the DNA assay were also used for measurement 
of total GAG. The dye solution was prepared from 16 µg/ml of 1,9- dimethyl-methylene 
blue (SigmaAldrich) in Milli-Q-filtered water, containing 0.03 M sodium formate (Sigma), 
0.2% formic acid (Sigma) and 0.5% ethanol, pH 6.8. Chondroitin 4-sulfate sodium salt 
from bovine trachea (Fluka) was used as a standard, prepared as serial dilutions in a 
buffer containing 0.03% alginic acid sodium salt (Fluka), 0.05 M sodium acetate 
anhydrous (Fluka), 5.5 mM Na3Citrate (Sigma), 3 mM Na2EDTA (Sigma), 18.75 mM 
NaCl (Fluka) and 0.05% Tween 20 (Sigma). Samples were diluted in the same buffer to 
match the linear range of the standard curve. Dye was added to samples and standards 
in a 96-well culture plate (Falcon), after all samples and standards were mixed with 
Guanidine Hydrochloride solution to a final concentration of 240 mM. Absorbance was 
measured immediately at 535nm and 595nm in the Bio Assay Reader. Using the 
absorbance ratio, total amounts of GAG were calculated from the linear range of the 
standard curve. All measurements were done in duplicates. 
Alkaline phosphatase (ALP) can be considered a marker of osteogenesis. Cells were 
released from alginate beads as described above with slight modifications. Three 
samples of three beads each were dissolved in a sterile dissolution buffer consisting of 
150 mM NaCl (Fluka) and 55 mM Na3Citrate.2H2O (Sigma). Cells were collected by 
centrifugation (10 minutes at 700 G). The pellet was resuspended in a 10mM Tris-HCl 
-23- 
 
buffered (pH 7.4) solution containing 0.1% Triton-X and extracted at 4°C under agitation 
for exactly 60 minutes. Samples were then centrifuged 10 minutes at 1000g to remove 
cells and cell debris, and the supernatant was transferred into a fresh tube. Samples 
were stored frozen at -20°C until analysis. Activity of ALP protein was measured by 
adding 50 µl of a substrate solution, containing 25 mg/ml of 4-nitrophenyl phosphate 
disodium salt hexahydrate (Sigma) in a 1M diethanolamine-buffered 0.5mM MgCl2 
solution (pH 9.8), to 100 µl of sample in 250 µl of alkaline buffer containing 1.5 M 2-
amino-2-methylpropanol (pH 10.3) and 100 µl of water, and incubating at 37°C for 
exactly 15 minutes. The reaction was stopped by addition of 500 µl of 0.1M NaOH. The 
amount of p-nitrophenol released was measured spectrophotometically at 405 nm, and 
amounts were calculated from a standard curve, prepared from a stock solution of p-
nitrophenol (Sigma) in the same buffer [41]. 
 
Histology 
Methanol fixed alginate beads or pellets were transferred to a 30% sucrose solution 
overnight, containing 0.1 M CaCl2 to prevent the beads from dissolving. Beads were 
soaked in Cryocompound (Leica) and sectioned on a cryotome to sections of 8 µm and 
mounted on SuperFrost Plus slides. Sections were kept frozen until stained.  
Alcian blue interacts with alginate but lowering the pH of the dye solution to 1.0 
suppresses background staining of alginate and enables a selective staining of sulfated 
PGs only [32]. Slides were rehydrated and transferred to 3% acetic acid for 3 minutes, 
then stained in alcian blue dye (1% w/v Alcian blue 8GX, Fluka, in 3 % acetic acid 
solution, containing 0.1 M CaCl2, pH adjusted to 1.0) for 30 minutes. Slides were 
washed in 0.1 M CaCl2, dehydrated and mounted with DPX water-free mountant 
(Sigma).  
Though described in the literature [42,43] alizarin red (AR) staining in alginate beads has 
its difficulties, since the beads are gelated through the addition of CaCl2 solution, bound 
to cause considerable background staining. The slides were rehydrated and stained in a 
filtered AR-solution (2% Alizarin Red S, Fluka, pH adjusted to 4.2 with ammonia), blot 
dried, and dipped in acetone [44], then dehydrated in xylene and mounted as described 
above. 
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Real Time RT-PCR  
Three times ten beads per group and time point were dissolved in the sterile dissolution 
buffer described above and cells were collected by centrifugation (10 minutes at 700g). 
Total RNA was then extracted from the samples using TRI Reagent with poliacrylic 
carrier (Molecular Research Center), and RNA was purified using the Sigma GenElute 
Mammalian Total RNA Miniprep Kit (Sigma), according to manufacturer’s directions. 
Isolated mRNA was transcribed to complementary DNA (cDNA), using Applied 
Biosystems reverse transcription kit and a reaction of 25°C for 10 minutes, 48°C for 30 
minutes, 95°C for five minutes on a thermo cycler (Eppendorf). The primers and probes 
(MicroSynth) used for the detection of collagen types I, II and X mRNA were custom 
designed and the sequences are listed in table 1. 18S ribosomal RNA (18S rRNA, 
Applied Biosystems) was used as endogenous control, and validation experiments for all 
primer-probe sets were performed on freshly isolated mRNA from the calcifying deep 
layer of articular cartilage from a bovine fetlock joint, as described elsewhere [45]. PCR 
was carried out using TaqMan PCR MasterMix (Applied Biosystems), with a 
concentration of 900 nM for the forward and reverse primers and 250 nM for the probes, 
and appropriate amounts of cDNA. The PCR was performed on an AB7500 system, 
running 2 minutes at 50°C, 10 minutes at 95°C followed by 40 cycles of 15 sec at 95°C 
and 1 min at 60°C for amplification, detecting fluorescence in Stage 3, Step 2. Data 
analysis was performed using the comparative CT method, using 18S rRNA as 
endogenous control and the day 0 control-group as calibrator [46]. 
 
Data Management and Statistical Analysis 
Raw data from measurement apparatus (Plate reader, Real-time PCR machine) was 
exported to CSV files, and imported into Microsoft Excel 2007 (Microsoft Corporation, 
Redmond, WA, USA). Data management, calculations from standard curves and dCt-
Calculations for RT-PCR, as well as averaging of duplicate or triplicate measurements of 
the same sample was completed using Microsoft Excel 2010. Calculated and averaged 
data was then transferred to Graph Pad Prism 5.04 (GraphPad Software Inc., La Jolla, 
CA, USA) for statistical analysis. Statistics were completed using multifactor ANOVA, 
and p-values were calculated with Bonferroni post-hoc tests from the ANOVA, and are 
stated in the text and graphs. P < 0.05 was assumed “significant difference”. All analysis 
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was completed with GraphPad Prism 5.04 for Windows, and all graphs were prepared 
with the same software. The authors received help with the statistical analysis by other 
persons as mentioned below (see acknowledgements). Unless stated otherwise, within 
the graphs, statistically significant difference between time points are indicated in 
asterisks as follows: *: p<0.05; **: p < 0.01; *** p < 0.001; ****: p < 0.0001. Statistically 
significant differences between treatment groups are indicated in crosses as follows: +: 
p<0.05; ++: p < 0.01; +++ p < 0.001; ++++: p < 0.0001. 
 
Results 
To compare primary chondrocytes to chondrogenically differentiated MSCs, the stem 
cells were differentiated in the alginate beads. During the differentiation, the cells 
acquired the properties of chondrocytes, including production of the cartilage-specific 
Col II and the production of a hyaline like extracellular matrix, composed of collagen and 
proteoglycans. Successful differentiation was therefore assumed with the expression of 
Col II mRNA and an increase in proteoglycan production.  
MSCs in alginate beads proliferated only little, and at day 21, DNA content was 
increased by app. 30%, while in pellet culture the total DNA content decreased by 20% 
during the differentiation period (see figure 2A). This decrease is associated with cell 
death in the center of the pellets, due to the lack of nutrients. The alginate bead hydrogel 
seems to bypass this problem, allowing nutrient supply even to the center of the bead. 
After establishing and testing the alginate bead cell culture system for the chondrogenic 
differentiation of mesenchymal stem cells, and for the culture of primary chondrocytes, 
the culture system was used to investigate whether or not T3 and Dex could influence 
chondrocyte differentiation towards hypertrophy and endochondral ossification. For this, 
the beads with chondrogenically differentiated MSCs, or serum precultured 
chondrocytes, were cultured in serum free medium containing either dexamethasone or 
T3 for five weeks 
No differences in DNA content were found between the chondrocyte treatment groups at 
any time point after “day 0”, which indicates the start of the hormonal treatment. In the 
MSCs, as described above, DNA content increased significantly during differentiation 
then dropped back to the levels of the initial seeding density within the first 7 days of 
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hormonal treatment. No differences in DNA content were seen due to the hormonal 
treatment (see figure 3). 
The mRNA levels of Col I, II and X over 21 days of MSC chondrogenesis are shown in 
figure 2B. Alginate beads with and without TGF-ß1 and pellet cultures with TGF-ß1, but 
not pellet cultures without TGF-ß1 showed a significant increase in Col II mRNA 
expression over control. The changes in Col I mRNA and Col X mRNA remained 
statistically insignificant, but the alginate beads showed a trend towards higher 
expression of Col X mRNA as compared to the pellets. As it was expected, Collagen 
Type II surpassed Collagen Type I as the most commonly expressed collagen mRNA in 
both structures when cultured in the presence of TGF-ß1.  
In articular chondrocytes, T3 had an up-regulating or stabilizing effect on mRNA 
expression of Col I and Col II. Col II was not significantly modulated by Dex, but after 
five weeks of culture, the T3 treated group showed the highest Col II mRNA, even 
surpassing the amounts in freshly isolated chondrocytes (P < 0.0001 at day 35, T3 vs. 
Control). Col I, foremost a marker of de-differentiation in the articular chondrocytes, was 
significantly decreased by Dex, and no up regulation occurred during the whole 
observation period. Control and T3 group, in contrast, showed a steady state to slight 
increase, starting after two weeks of culture. With regard to Col I, Dex had a very similar 
decreasing effect on the chondrogenically differentiated MSCs as on adult chondrocytes 
(with P < 0.05 on day 14 vs. control, and P < 0.0001 thereafter). T3 had no effect 
significantly different than from the control group, and by day 35, Col I mRNA levels in T3 
and control group were not significantly different than on day 0. For Col II, however, T3 
significantly decreased mRNA expression as compared to control (P < 0.001 at day 21, 
and P < 0.0001 afterwards), while the levels remained mostly stable under control 
treatment or with Dex supplementation, thereby showing a reversed effect on the 
hormones when compared to adult chondrocytes (see figure 4).  
Col X mRNA expression and ALP protein activity were monitored over the culture period 
as markers of hypertrophy (figure 5). Collagen Type X mRNA was found to be 
unexpectedly high in the freshly seeded chondrocyte beads. It rapidly decreased two to 
three orders of magnitude (P < 0.0001, day -14 vs. day 0) by week two or three, to then 
rise again only in the presence of T3. Control and Dex groups remained rather low, or 
increased only slowly. After 5 weeks of hormonal treatment, Collagen X levels were 
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highest in the T3 treated groups, surpassing the other groups 10 to 20 fold and reaching 
up to 25% of the initial amounts at day 0. Initially rather low, the ALP activity was 
increased significantly during serum preculture (P < 0.05, day -14 vs. day 0), to then 
drop again when treated with control medium or Dex, with the drop quickest in the 
control group (P < 0.05, Dex and T3 vs. Control on day 14). Correlating to the increase in 
col X mRNA, ALP activity also went up in the T3-treated chondrocyte group (P < 0.0001, 
T3 vs. Control and significantly higher than at day 0, P < 0.0001).   
The chondrogenically differentiated MSCs showed no change in Col X mRNA 
expression in response to T3 over the culture period of five weeks, as compared to 
control or over time. After the aforementioned increase during the differentiation, the 
levels of Col X mRNA remained stable, with a slight but non-significant tendency to 
decrease during culture with T3. In the MSCs, Dex had a significant impact, and 
increased Col X mRNA production significantly over time (P < 0.0001, from day 21 on) 
and against control group (P < 0.0001, Dex vs. control after 21 days). After five weeks, 
Col X mRNA levels were increased by two orders of magnitude compared to start of 
induction. 
In contrast to articular chondrocytes, freshly isolated MSCs showed no measurable ALP 
protein activity. Expansion in monolayer did not change this. After encapsulation and 
chondrogenic differentiation, ALP activity became measurable and rose significantly to 
levels comparable to those of serum-cultured articular chondrocytes (figure 5, P < 
0.0001, day -21 vs. day 0). With removal of serum supplement and start of the induction, 
ALP activity dropped again in all three groups (P < 0.01, day 14 vs. day 0), and only with 
Dex was the activity after 35 days significantly higher than at day 0 (P < 0.05) and higher 
than in the control group (P < 0.001), correlating with the results from the Col X mRNA 
findings.  
Proteoglycan production did not show much difference between the two groups, both in 
pellets and beads, cells produced significant amounts of glycosaminoglycan’s, as it is 
typical of chondrogenic cells.  
Collagen, however, was either not produced in the pellets, or was not bound within and 
was lost during medium changes and washing. The alginate bead system, suspending 
the cells in a three dimensional hydrogel, seems to allow for a better deposition and 
binding of extra cellular matrix proteins. 
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To evaluate the distribution of the cells within the beads and pellets, cryosections were 
stained for glycosaminoglycans with alcian blue. Cells could be seen distributed evenly 
throughout the alginate beads. Compared to the pellet cultures, alginate beads are 
larger in size and with a lower cell density; therefore the gaps between nuclei are much 
larger. Figure 6 illustrates the two culture systems, confirming the comparable amount of 
proteoglycans within the structures. 
Proteoglycans are the major component of the cartilage ECM. The total proteoglycan 
content was analyzed from the same weekly samples as DNA content, and normalized 
to DNA amount to equalize for the differences in bead size and cell density. Any 
increase in GAGs can therefore be contributed to an increased synthesis per cell. Only 
the GAGs retained within the alginate beads were quantified. The results are displayed 
in figure 7.  
GAG content of freshly prepared chondrocyte beads after cell isolation and matrix 
digestion was low as expected and increased during serum preculture. Thereafter, only 
with Dex did the production increase further. The MSCs displayed a similar pattern as 
the articular chondrocytes. As stated above, the total amount of GAG had already 
increased during the chondrogenic differentiation period (see figure 2A), comparable to 
the GAG production of the chondrocytes during the serum pretreatment phase. 
Subsequently, the GAG content increased significantly only in the Dex-treated group, as 
seen with articular chondrocytes. While articular chondrocytes displayed a slow increase 
in GAG/DNA in the T3-treated group, this effect was not visible with the MSCs. In 
contrast, the relative amount of GAG seemed to drop, though not significantly, from day 
21 on. Without any hormonal supplements, in the control group, the GAG content was 
steady and showed significant increase at day 35 (P < 0.01 vs. day 0, and significantly 
higher with P < 0.001 vs. T3 at the same time). 
Alcian Blue staining of cryosectioned alginate beads for glycosaminoglycans was 
completed to confirm findings of biochemical analysis. After five weeks of culture, cells 
demonstrate a typical chondrogenic phenotype with a darker stained ring of pericellular 
matrix around each cell. In histology, no difference was seen between the Dex and T3 
group, and both showed intense uptake of alcian blue (figure 8). 
To determine whether the changes in the mRNA expression actually lead to differences 
in collagen production levels, total hydroxyproline per DNA was measured in the 
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samples. The T3 group in the chondrocytes seems to show an increase over control and 
Dex after 14 and 35 days, an effect that was not seen in the MSCs (see figure 9).  
During chondrogenesis of the MSCs, the cells produced significant amounts of HYP (as 
already shown in figure 2), but in both T3 and Dex groups this did not increase any 
further afterwards. Only in the control group did the content continue to rise. Except for 
the statistically significant increase from day -21 to day 0 (P < 0.0001), none of the 
changes seen were statistically significant.  
The alizarin red staining of samples to investigate calcification led to a degree of 
background staining due to the calcium present to gelate the alginate.  In our hands, this 
background staining with alizarin red was present on freshly prepared and cultured 
beads alike (see Figure 10). 
Despite the backgroup staining observed, differences could be detected. For MSC 
beads, an increase in the AR staining intensity was observed from day -21 and day 0. 
The Dex-treated beads then showed a much more intense staining, and at higher 
magnification, the Dex-treated cells showed a pericellular matrix and dark red calcium 
depositions around the cells, which was not seen at this intensity in the other samples 
(Figure 11). The same impression was gained from the T3-stained chondrocyte beads, 
showing a more heterogeneous stain of AR after induction. However, this effect was not 
very pronounced and evaluation is more subjective (see Figure 12). The results of the 
AR staining in general reflect the results of ALP quantification. 
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Discussion 
In this study, we investigated the effects of two hormones, T3 and Dex, on chondrocytes 
and chondrogenically differentiated MSCs in different settings, aiming to determine if 
and how these hormones would influence cell proliferation, matrix production and the 
expression of Col I, Col II and Col X mRNA as markers for phenotypic stability. We had 
hypothesized that the hormones would induce Collagen X expression, ALP protein 
activity and increased calcification as markers of terminal differentiation. We also 
expected articular chondrocytes and chondrogenically differentiated MSCs to be similar 
in their response to the hormonal stimuli. 
We have used full thickness cartilage from bovine fetlock joints as a source of articular 
chondrocytes, and encapsuled the cells into alginate beads. The cells were seeded at a 
concentration of app. 4*106 cells / ml of alginate, a concentration that is likely to be close 
to the cell density in human adult knee cartilage [47]. Experiments were conducted on 
cells of three different animals, with the cells from each animal kept individually at all 
times. The resulting variance between the different runs of the experiment account for 
the possible bandwidth of inter-individual stimuli response. Stripping the cells of almost 
all their matrix is likely to influence the cellular response to any stimulus [48], but is 
unavoidable during cartilage digest.  
Most of the cells acquired in the digestion process were fully differentiated into the 
articular chondrocyte phenotype, as seen with Col II mRNA being expressed in high 
amounts and very little Col I mRNA being expressed. Unexpectedly there was 
considerably high expression of Col X mRNA in the freshly isolated chondrocytes. In 
young animals, ossification is still occurring in the lower level of articular cartilage where 
it is directly adjacent to bone. Though care was taken during harvest not to scrape into 
the mineralizing layer, it is possible cells were taken from the calcifying zone that were 
expressing both Col X mRNA and ALP activity [49]. A rapid down-regulation in all groups 
during the first weeks of culture indicates that whatever cells expressing the Col X 
mRNA either stopped doing so or potentially completed the process of terminal 
differentiation and underwent apoptosis. Further work would be required to determine 
which process actually occurred. 
The cells readily responded to serum as a medium supplement inducing proliferation 
and matrix production. In the presence of serum, the cells doubled in number within two 
-31- 
 
weeks, and produced both collagen and proteoglycan as the typical markers of adult 
chondrocytes. However, we also saw the previously described trend towards a 
dedifferentiation [50] by way of a rise in Col I mRNA, even though the cells were 
encapsuled in a three dimensional culture system. For the further study of the specific 
effects of the selected hormones, FCS was omitted in the induction phase of the 
experiments. In serum-free medium, proliferation and matrix production are mostly 
arrested, but non-supplemented ITS medium was sufficient at all times to support the 
number of chondrocytes initially entrapped in the beads over a culture period of 35 days 
in our hands as in other studies [51].  
This did not hold true for MSCs: Their count decreased significantly when medium was 
changed from differentiation medium (with TGF-ß1 and Dex) to the serum-free medium. 
The most common and best described method of chondrogenic differentiation of MSCs 
is that of pellet culture under the influence of TGF-β, resulting in differentiation towards a 
chondrocyte-like phenotype, characterized by upregulation of cartilage-specific mRNA  
and cartilage ECM molecules such as collagens and proteoglycans [52]. Apart from the 
fact that the cells cannot be separated out of these high density cultures after 
differentiation, these common in vitro conditions can also induce features of 
fibrocartilage (Col I) as well as features typical of hypertrophy (Col X and ALP) [8,53]. 
The encapsulation of MSCs into alginate beads for differentiation and further use 
therefore seemed beneficial to us and others in this setting [54]. The expression pattern 
of Col I, II and X was comparable to those of pellet cultures, and even without TGF-ß, 
cells differentiated chondrogenically in alginate. In alginate culture, the cells had a non-
significant increase in Col X mRNA, accompanied by an increase of ALP activity. It was 
speculated elsewhere that there is no stable arrest in MSCs after differentiation and 
before hypertrophy [8]. The matrix production in alginate exceeded that of the pellet 
cultures in means of collagen production or retention, but not in proteoglycan content.  
We have treated the entrapped cells with two different agents in a chemically defined 
medium to investigate the effect of the hormones in regards to cell proliferation, matrix 
production and collagen expression pattern. Our main issues were phenotypic stability 
as well as signs of terminal differentiation of the chondrocytes. 
Review of the literature shows many studies using T3 on chondrocytes of different origin, 
mostly growth plate and fetal, and in many different culture systems and media 
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conditions. While human articular chondrocytes subjected to T3 in monolayer and serum 
containing medium showed enhanced proliferation [55], earlier studies showed no effect 
of T3 or T4 on adult bovine cartilage cell proliferation or GAG synthesis in high-density 
cultures in serum-free medium [56]. This is consistent with our findings of no difference 
between T3-treated chondrocytes vs. control in means of DNA and GAG content, and in 
line with other studies performed in serum-free medium [57]. The continuous production 
of GAGs within the beads also indicates a stable chondrocytic phenotype of the cells, 
and stains on cryosectioned beads towards the end of the culture period confirmed the 
deposition of a pericellular matrix around the chondrocytes, as described by others [35]. 
Obviously, matrix synthesis and cell proliferation are influenced by a vast number of 
factors, including nutrient supply, cell culture system and seeding density, which 
potentially overrule the possible stimulation by growth hormone T3. 
As markers for chondrocyte hypertrophy we have measured Col X mRNA levels, ALP 
protein activity in the beads and evaluated calcium incorporation histologically. Collagen 
Type X is considered a marker of chondrocyte hypertrophy and has been frequently 
used as such in many publications. Along with its appearance in the growth plate, Col X 
mRNA is also expressed by chondrocytes in osteoarthritic joints [58]. Over the whole 
culture period, T3 generally had an upregulating effect on all types of Col mRNA, 
including Col X mRNA. While the receptor  and pathways  of T3 induced effects in 
growth plate chondrocytes could be recently identified [59], this has not been sufficiently 
studied in articular chondrocytes. By proving that paracrine signaling via PTHrP can stop 
the hypertrophic effect of T3, it seems likely that these pathways, remnants of the growth 
plate cartilage, are still active in the “permanent” articular chondrocytes as well [60]. In 
other experiments, T3 was found to be stabilizing dedifferentiated human chondrocytes 
of various sources and inhibit hypertrophy-inducing effects of other agents [61]. Adult 
porcine articular chondrocytes have a high affinity receptor for T3 and show enhanced 
ALP activity and an increase in Col X production when stimulated in monolayer and 
serum culture [62]. 
In our study, T3 in the absence of Dex also showed a tendency to induce terminal 
differentiation in the articular chondrocytes. The increase in Col X mRNA was 
accompanied by a rise in ALP activity over the control group. Apoptosis is closely 
associated with terminal chondrocyte differentiation [63], but no decline in DNA content 
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was detected in our experiments, and no screening test for apoptosis was completed. 
Possibly, terminal differentiation does not progress to the final apoptotic step within the 
culture period applied. It has also been suggested that hypertrophy and apoptosis might 
not necessarily be linked, but regulated along different pathways [64]. We also failed to 
show other features of hypertrophy such as significant changes in cell morphology, 
although the alizarin red staining suggested there was potentially a slight increase in 
calcium deposition. Therefore it is possible that T3 in the absence of Dex is sufficient to 
promote Collagen X expression in the articular chondrocytes, but does not necessarily 
induce the full features of the hypertrophic chondrocyte. The differential effect of T3 on 
collagen type II and col X gene expression in chondrocytes and chondrogenically 
induced MSCs would suggest that they are not at the same developmental stage. For 
both collagens, addition of T3 lead to an increased expression in chondrocytes 
compared to control, which was not seen in chondrogenically induced MSCs.  
The facts currently known about an effect of T3 on chondrogenically differentiated MSCs 
are very sparse, but evidence suggests that removal of TGF-ß, reduction of Dex and 
addition of T3 should induce hypertrophy in the chondrogenically differentiated MSCs at 
least in pellet culture [65]. Here is should be noted, these experiments were performed 
in the complete absence of Dex and this might explain the differences seen with other 
studies. Other authors have suggested a dose-dependent effect of T3, promoting MSC 
osteogenic differentiation at 10 pM [66]. We had hypothesized that a chondrogenically 
differentiated MSC, thereby becoming a chondrocyte-like cell, would react like a 
chondrocyte, which it did not. T3 had little effect at all on the MSCs, the only significant 
difference was a marked and steady decrease in Col II mRNA, while Col I and X mRNA 
levels remained stable. Indeed, if T3 is suitable to promote a more osteogenic phenotype 
in MSCs, this would be in line with the some of the evidence available so far. The dose 
used in our experiments was identical for chondrocytes and MSCs, and therefore 100-
fold higher than the dose used before to induce hypertrophy in pellet cultures – on the 
other hand, the use of Dex in those experiments might also be a key factor, as 
discussed further below. 
It is striking that especially the differentiated MSCs of the control group in serum-free 
ITS-supplemented medium do seem to remain in their chondrocyte-like phenotype over 
five weeks, with no significant increase of ALP protein activity and no increase in Col X 
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mRNA expression. Alginate as the chosen scaffold material might also have a certain 
influence to this fact. Alginate binds divalent calcium ions, producing a positive charge 
within the gel, a feature that seems beneficent to chondrogenesis, as surface 
chemistries promoting a rounded cell morphology in general seem to do [67]. On the 
downside this arrest essentially stops all matrix production, for without further 
supplementation, the production of GAG within the beads is rather low, and there is a 
decrease in DNA as a sign of cell death and arrest of proliferation.  
The second hormone investigated in this study was dexamethasone. As with T3, the 
effect of Dex on the growth plate is a matter of ongoing research, but without doubt, 
glucocorticoids such as Dex have a major role in the development of the growing 
skeleton, both through systemic [68] as well as local effects on the growth plate [69]. 
Besides their clinical use on inflamed joints , GCs find frequent use on articular and 
other chondrocytes in culture, with their effect on cell proliferation, matrix synthesis and 
gene expression being dependent on cell source, culture system, cell density and dose 
of GCs used.  
Looking at cell survival, no significant differences between the Dex-treated alginate 
beads versus control or T3-treated beads was observed. While some studies describe a 
decreased cell survival or increase of apoptosis in chondrocytes submitted to Dex or 
other steroids in vitro [22,70] and in vivo [21], others find a protective effect of Dex 
against apoptosis induced by other factors such as mechanical loading [71]. We have 
not completed stains or assays to test for apoptosis, and DNA content alone is not a 
sufficient analysis to out rule apoptotic processes in the beads, but again, microscopic 
imaging did not show signs of such. 
Dex is capable of regulating both degrading and matrix-building components of the ECM 
in a dose-dependent manner. In the current literature, numerous, partly conflicting 
results have been reported [72,73]. We found that the Dex-treated chondrocytes 
produced more matrix significantly faster than the control group or the T3 treated group. 
Such an increase in GAG production was seen by others previously [74]. We postulate 
that many of the catabolic effects on proteoglycan synthesis seen elsewhere relate to 
the use of co-factors such as TGF-ß, while for Dex alone in a chemically defined 
medium, the anabolic effects on glycosaminoglycan production can be demonstrated. 
Still, we can also confirm the often-quoted [75] downregulation of Col Type II mRNA. 
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Along with it, we also report a general downregulation of all types of Collagen mRNA 
measured, most significantly Col I mRNA. If Dex can be used to negate the 
dedifferentiating influences of other agents, as suggested by the decreasing Col I mRNA 
levels, it could be an issue for future investigations. Notably, trends of mRNA expression 
seen in the initial phase of cell culture rarely continued during the later phase of the 
experiment. Expression levels either stabilized or changed after two or three weeks in 
culture, stressing the importance of long term experiments as well as regular time points 
to monitor cellular response. The initial downward trend in collagen expression never 
reversed in the Dex-treated group, and continued throughout the culture period for Col II 
mRNA. In long term cultures, this may destabilize the ECM.  
Apart from its previously debated apoptotic effect, Dex is also under debate as an 
inductor of chondrocyte terminal differentiation. Addition of Dex, to monolayer human 
chondrocytes in serum supplemented culture increased hypertrophy and apoptosis [76], 
but not in a serum-free environment [26]. In the course of our experiments, investigating 
Col X mRNA, ALP activity and cell morphology, we have found no evidence of Dex 
inducing the bovine articular chondrocytes to terminal differentiation. To our knowledge, 
there is no study on adult articular chondrocytes in a 3D-environment proving otherwise. 
On the matter of Dex and undifferentiated MSCs, the issue seems to be much clearer. 
Dex is an inherent part in the osteogenic differentiation of MSCs, and also included in 
the formulations of chondrogenic and adipogenic differentiation media, as we have also 
used it for the differentiation in this study. We saw that the chondrocyte-like cells 
differentiated from MSCs did not benefit from a further supplementation of Dex in the 
medium in means of cell survival. With the withdrawal of TGF-ß1 after successful 
chondrogenic induction, DNA quantities dropped significantly with or without Dex. The 
cells were indeed chondrocyte-like in means of GAG production, which was also 
enhanced by Dex in the serum.  
Phenotypic stability is a major issue with MSCs in tissue engineering, especially when 
aiming for a cartilage repair graft. For this reason, differentiated MSCs must be 
committed to their cartilage-like gene expression pattern, also in the absence of 
chondrogenic factors or in the presence of osteogenic factors, a feature that seems to 
be created even through a short TGF-ß exposure [77]. The absence of TGF-ß did not 
cause a loss of cartilage-like gene expression pattern in our hand, but the addition of 
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Dex, as an osteogenic factor, did. Col II mRNA remained stable, but Col X mRNA did 
increase considerably and steadily with Dex in the medium. Others have discovered 
similar effects, for example was it shown for human MSCs in three dimensional alginate 
bead culture to express Col X, after only one week of treatment in Dex and TGF-ß1 
containing medium [20]. It seems that this process is not interrupted through priming to 
the chondrogenic phenotype with TGF-ß. While we also saw the up-regulation of the 
chondrogenic gene Col II during in vitro induction of chondrogenesis, the differentiating 
cells also exhibited Col X as a marker of hypertrophy. The phenotype of MSCs in 
cartilage repair can therefore be so unstable that differentiation will continue along the 
endochondral ossification pathway, especially with Dex present in the medium [67]. 
While unfavorable for cartilage, this gives rise the possibility to engineer MSC-based 
bone grafts, recapitulating the processes of endochondral ossification, acknowledging 
the “paradigm shift” of developmental engineering [78].  
In summary, chondrocytes are capable of more than merely synthesizing cartilage 
matrix. Their terminal differentiation is an important process in long bone growth and 
secondary fracture healing. It is also suspected that it plays a role in onset of 
degenerative OA, yet the factors that influence it are poorly understood. Also, 
chondrocytes from various sources show different behavior towards their response to 
any stimuli. Without defined conditions, a comparison of completed studies is without 
benefit. Currently, too little work is completed on primary adult chondrocytes to lead to 
later clinical applications. In this study we have taken a step towards probing T3 as an 
inductor of chondrocyte hypertrophy in postnatal immature articular chondrocytes. We 
have also shown a contrary effect of Dex to contribute to the ongoing discussion of the 
use of this hormone in cartilage tissue engineering. We also want to suggest the idea 
that even those chondrocytes deemed “permanent” may not be so, but rather be “slow 
transient” in their response to stimuli, a fact that must be considered when using these 
cells in tissue engineering applications. 
The use of MSCs in bone and cartilage tissue engineering is well established, but 
phenotypic stability is a major issue, especially when aiming for a cartilage repair graft. It 
remains under debate whether or not the phenotype of the chondrocyte-like cell after 
differentiation is stable enough to be used in cartilage repair. When MSCs are indeed 
moving on towards terminal differentiation after chondrogenic differentiation, they can be 
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used to generate a model of endochondral ossification. We can contribute with our 
results, recommending the use of alginate beads rather than micromass pellet cultures 
as a scaffold, and the use of Dex to trigger Col X mRNA expression in these cells. 
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Figures 
Figure 1: Experimental layout and timepoints 
 
MSCs were harvested from the tuber ischiadicum and chondrocytes from fetlock joints, 
and both cells were encapsuled in alginate beads. While the MSCs were differentiated 
chondrogenically for three weeks (day -21 to day 0), the chondrocytes were kept in 
serum medium for two weeks (day -14 to day 0). The beads were then submitted to 
hormonal treatment for five weeks (day 0 to day 35) with weekly samples for analysis. 
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Figure 2: Production of DNA, GAG and HYP and collagen mRNA expression 
during chondrogenic MSC differentiation 
 
The upper graph A shows the changes in total DNA content per bead (or per pellet, 
respectively) during the differentiation and the increase of proteoglycans and 
hydroxyproline as a sign of extra cellular matrix production. Both pellet cultures and 
alginate bead cultures show an increase in GAG, but only in alginate beads, also 
collagen is produced and retained. Shown is the mean of three samples per animal 
(n=6) +/- standard error of the mean (SEM).  
The lower graph B shows the fold-increase (mean +/- SD) of collagen mRNA, compared 
to undifferentiated MSCs kept in monolayer in expansion medium for 3 weeks. The bars 
compare alginate beads with and without TGF-ß1 vs. pellet cultures with and without 
TGF-ß1. Alginate beads with TGF-ß1 show the highest increase in Col II mRNA 
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expression, indicating that the culture system is well suited for chondrogenic 
differentiation of the MSCs. 
 
Figure 3: DNA content over time 
 
Shown is the relative DNA content in articular chondrocytes (A), with day 0 being the 
reference and indicating the beginning of the hormonal treatment phase and day -14 
showing the DNA content right after encapsulation. DNA content ranged from 96% to 
121% of day 0 amounts, with no significant differences between treatment groups or 
over time. The second graph (B) shows the DNA content in the MSCs before and during 
differentiation (Day -21 to Day 0) and under the influence of T3 and Dex. The significant 
cell proliferation that occurred during the chondrogenic differentiation (Day 0 vs. Day  21, 
p<0.01) did not continue in the serum free treatment medium, indicating its dependence 
on TGF-ß1. 
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Figure 4: mRNA expression of Col I and Col II 
 
Displayed is the relative change in Col type I and II mRNA in chondrocytes (A and B) 
under hormonal treatment vs. control, and in the MSCs (C and D, respectively). The 
expression was calibrated to 18S and normalized to control at day 0. Dex decreased Col 
I mRNA expression in both cell types significantly, but in greater scale in the 
chondrocytes (Dex vs. control with P < 0.001 after 21 days of culture). Col II mRNA was 
not significantly regulated by Dex, but decreased through T3 in MSCs and increased in 
chondrocytes.  
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Figure 5: Markers of hypertrophy in chondrocyte and MSC culture 
 
Shown is the relative change in Col type X mRNA in chondrocytes (A) and MSCs (B) 
and the total level of ALP activity (C and D, respectively). Both markers demonstrate that 
for articular chondrocytes, T3 can induce terminal differentiation in the cells, while 
chondrogenically differentiated MSCs show a similar response but to dexamethasone 
instead. 
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Figure 6: Stained cryosections of a pellet culture and an alginate bead 
 
Alcian blue stain of 8 µm Cryosections of an alginate bead culture (A) and an MSC pellet 
culture (B) after 21 days of chondrogenic differentiation. Proteoglycans show in blue. 
The gaps in the alginate bead section are artifacts from the cutting. The scale bar 
represents 500 µm.  
 
Figure 7: GAG content over time in the treatment groups 
 
Shown is the relative GAG per DNA content of chondrocytes (A) and MSCs (B), with day 
0 being the reference and indicating the beginning of the hormonal treatment. Absolute 
amounts of GAG reached more than 60 µg GAG/µg DNA or more than 80 µg of GAG 
per bead in the Dex group. After changing to serum-free hormonal treatment medium, 
Dex enhanced the GAG production significantly more than T3 or control medium (seen 
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from day 21 on, with P < 0.001) and showed a general increase over time. A further 
increase with T3 after preculture serum showed only at day 28 (P < 0.01 vs. day 0), the 
control group had no significant increase in GAG/DNA after change to serum free 
medium. The MSCs behaved similar in their response to Dex, with significant increase in 
GAG production after two weeks (P < 0.01 at day 14 and 21 vs. day 0, and P < 0.0001 
afterwards), but T3 seemed to rather decrease GAG production 
 
Figure 8: Proteoglycan visualization in alcian blue staining of alginate beads 
 
Freshly prepared beads (A) only have slight background staining of alcian blue, almost 
all proteoglycans are removed from the cells during the digestion process. In the 
overview after serum preculture and five weeks of culture (B), the cells impose as round, 
singular cells with surrounding deep-blue pericellular matrix and further removed matrix 
in the gel. No differences can be visualized in the GAG content between T3-treated (C) 
and Dex-treated (D) chondrocytes. 
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Figure 9: Hydroxyproline production in chondrocytes 
 
Total amount of HYP was quantified and calibrated to the total amount of DNA, to 
equalize for production merely due to increased or decreased cell number. Shown are 
the results of the quantification in the articular chondrocytes (A) and the MSCs (B) 
before and during hormonal treatment, as mean +/- SD. 
 
Figure 10: Alizarin red background stain in alginate beads 
 
Freshly prepared beads, stained with AR with (A) representing a bead seeded with 
chondrocytes and (B) a bead with MSCs. Both show considerable high but very similar 
background staining, due to the use of CaCl2 for crosslinking. The calcium ions remain 
crosslinked in the alginate throughout the culture period.  
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Figure 11: Calcium incorporation in alginate beads with MSCs  
 
For MSC beads, we found an increase in the uptake of AR from day -21 (A) before 
differentiation and day 0 (B). The Dex-treated beads then showed a much more intense 
staining, and at higher magnification, the Dex-treated cells (D) showed a pericellular 
matrix and dark red calcium depositions around the cells, which was not seen at this 
intensity in the other, T3-treated samples (C). 
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Figure 12: Calcium incorporation in alginate beads with chondrocytes  
 
Between day -14 (A) and day 0 (B) no major increase was seen in AR uptake. 
Chondrocyte seeded beads treated with T3 (C) showed then a more heterogeneous 
stain of AR after induction, as compared to the dex-treated group (D). 
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Tables 
Table 1: Primer and probe sequences used for RT-PCR 
Gene  Primer fw 5’-3’ Primer rev 5’-3’  Probe 5’FAM/3’TAMRA 
Procollagen 
1A2 (bCol 1) 
149TGC AGT AAC TTC 
GTG CCT AGC A170 
234CGC GTG GTC 
CTC TAT CTC 
CA215 
172CAT GCC AAT CCT 
TAC AAG AGG CAA 
CTG C199 
Procollagen 
2A1 (bCol 2) 
112AAG AAA CAC 
ATC TGG TTT GGA 
GAA A136 
187TGG GAG CCA 
GGT TGT CAT 
C169 
141CAA CGG TGG CTT 
CCA CTT CAG CTA 
TGG167 
Collagen X 
(bCol X) 
1923ACT TCT CTT 
ACC ACA TAC ACG 
TGA AAG1949 
2030CCA GGT AGC 
CCT TGA TGT 
ACT CA2008 
1985TGC CGT TCT TAT 
ACA GAC CTA CCC 
AAG CAT G1955 
 
Sequences of forward and reverse primers and probes used for the real time RT-PCR. 
Probes and primers were self-designed and supplied by MycroSynth (Switzerland) and 
prepared according to manufactures directions. Validation experiments on bovine 
articular chondrocytes and growth plate chondrocytes were carried out to verify equal 
efficiency. 
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